Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CVS
|
Michael F Mahoney
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,200 Added 26.19% |
$125,620
$57.1 p/Share
|
Nov 21
2024 |
|
TRST
|
Robert M Leonard
EVP & CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 1,600 Added 4.5% |
-
|
Nov 21
2024 |
|
TRST
|
Robert M Leonard
EVP & CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 750 Reduced 2.21% |
$27,577
$36.77 p/Share
|
Nov 21
2024 |
|
CVS
|
Fernando Aguirre
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,364 Added 6.02% |
$134,984
$57.1 p/Share
|
Nov 21
2024 |
|
CVS
|
Jeffrey R. Balser
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,375 Added 19.75% |
$135,612
$57.1 p/Share
|
Nov 21
2024 |
|
LICY
|
Anthony Tse |
BUY
Grant, award, or other acquisition
|
Direct | 26,434 Added 20.13% |
-
|
Nov 21
2024 |
|
BENF
|
Karen Wendel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 207,317 Added 50.0% |
-
|
Nov 21
2024 |
|
FSFG
|
Troy D. Hanke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 6.67% |
-
|
Nov 21
2024 |
|
CVS
|
C David Brown Ii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,331 Added 1.85% |
$133,100
$57.1 p/Share
|
Nov 21
2024 |
|
LICY
|
Mark Wellings |
BUY
Grant, award, or other acquisition
|
Direct | 31,129 Added 17.98% |
-
|
Nov 21
2024 |
|
FSFG
|
Steven R Stemler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 0.94% |
-
|
Nov 21
2024 |
|
MNST
|
Emelie Tirre
Chief Commercial Officer |
SELL
Bona fide gift
|
Direct | 932 Reduced 1.21% |
-
|
Nov 21
2024 |
|
MNST
|
Emelie Tirre
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,350 Added 4.16% |
$99,964
$29.84 p/Share
|
Nov 21
2024 |
|
SOUN
|
Lawrence Marcus |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.0% |
$214,500
$7.15 p/Share
|
Nov 21
2024 |
|
TRST
|
Curtis N Powell |
SELL
Sale (or disposition) back to the issuer
|
Direct | 739 Reduced 28.35% |
$27,173
$36.77 p/Share
|
Nov 21
2024 |
|
TRST
|
Curtis N Powell |
BUY
Exercise of conversion of derivative security
|
Direct | 739 Added 22.09% |
-
|
Nov 21
2024 |
|
BBAI
|
Bbai Ultimate Holdings, LLC |
SELL
Open market or private sale
|
Indirect | 1,821,619 Reduced 0.0% |
$4,025,777
$2.21 p/Share
|
Nov 21
2024 |
|
TRST
|
Kimberly Adams Russell |
SELL
Sale (or disposition) back to the issuer
|
Direct | 739 Reduced 13.59% |
$27,173
$36.77 p/Share
|
Nov 21
2024 |
|
TRST
|
Kimberly Adams Russell |
BUY
Exercise of conversion of derivative security
|
Direct | 739 Added 11.96% |
-
|
Nov 21
2024 |
|
ZION
|
Jason D. Arbuckle
SVP - Controller |
SELL
Open market or private sale
|
Direct | 147 Reduced 8.75% |
$8,699
$59.18 p/Share
|
Nov 21
2024 |
|
SQ
|
Brian Grassadonia
Cash App Lead |
SELL
Open market or private sale
|
Direct | 8,328 Reduced 1.46% |
$758,764
$91.11 p/Share
|
Nov 21
2024 |
|
COCO
|
Jane Prior
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 3,888 Reduced 2.86% |
$143,894
$37.01 p/Share
|
Nov 21
2024 |
|
COCO
|
Jane Prior
Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,888 Added 2.78% |
$39,579
$10.18 p/Share
|
Nov 21
2024 |
|
FICO
|
James M Wehmann
Executive Vice President |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 6.68% |
$8,125,809
$2321.66 p/Share
|
Nov 21
2024 |
|
SQ
|
Amrita Ahuja
CFO & COO |
SELL
Open market or private sale
|
Direct | 6,661 Reduced 2.63% |
$609,015
$91.43 p/Share
|
Nov 21
2024 |
|
DBVT
|
Virginie Boucinha
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 19,000 Added 33.33% |
-
|
Nov 21
2024 |
|
ACR-PD
|
Eagle Point Credit Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,674 Reduced 0.0% |
$42,034
$25.11 p/Share
|
Nov 21
2024 |
|
SQ
|
Ajmere Dale
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,781 Reduced 2.03% |
$162,836
$91.43 p/Share
|
Nov 21
2024 |
|
DBVT
|
Pharis Mohideen
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,350 Reduced 2.05% |
$1,269
$0.54 p/Share
|
Nov 21
2024 |
|
DBVT
|
Pharis Mohideen
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,000 Added 23.43% |
-
|
Nov 21
2024 |
|
SQ
|
Chrysty Esperanza
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 1,961 Reduced 2.24% |
$179,294
$91.43 p/Share
|
Nov 21
2024 |
|
DFH
|
Patrick O. Zalupski
President and CEO |
SELL
Open market or private sale
|
Direct | 117,224 Reduced 16.89% |
$3,677,316
$31.37 p/Share
|
Nov 21
2024 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 0.0% |
$95,850
$6.39 p/Share
|
Nov 21
2024 |
|
PNM
|
Norman P. Becker |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 8.31% |
$111,366
$48.42 p/Share
|
Nov 21
2024 |
|
NRDY
|
Abigail Blunt
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 14.18% |
$27,799
$1.39 p/Share
|
Nov 21
2024 |
|
NRDY
|
Charles K. Cohn
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 136,753 Added 0.0% |
$175,043
$1.28 p/Share
|
Nov 21
2024 |
|
SHW
|
Allen J Mistysyn
SVP - Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 784 Reduced 1.2% |
$299,346
$381.82 p/Share
|
Nov 21
2024 |
|
SHW
|
Allen J Mistysyn
SVP - Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,706 Added 2.57% |
$313,187
$183.58 p/Share
|
Nov 21
2024 |
|
SHW
|
Allen J Mistysyn
SVP - Finance & CFO |
SELL
Bona fide gift
|
Direct | 900 Reduced 1.4% |
-
|
Nov 21
2024 |
|
TRST
|
Lisa M Lucarelli |
SELL
Sale (or disposition) back to the issuer
|
Direct | 739 Reduced 21.12% |
$27,173
$36.77 p/Share
|
Nov 21
2024 |
|
TRST
|
Lisa M Lucarelli |
BUY
Exercise of conversion of derivative security
|
Direct | 739 Added 17.44% |
-
|
Nov 21
2024 |
|
DORM
|
Joseph P. Braun
SVP and General Counsel |
SELL
Open market or private sale
|
Direct | 6,286 Reduced 31.34% |
$854,896
$136.0 p/Share
|
Nov 21
2024 |
|
DORM
|
Joseph P. Braun
SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 6,286 Added 23.86% |
$387,720
$61.68 p/Share
|
Nov 21
2024 |
|
GEVO
|
Kimberly T Bowron
Chief People and IT Officer |
SELL
Open market or private sale
|
Indirect | 14,240 Reduced 0.0% |
$18,369
$1.29 p/Share
|
Nov 21
2024 |
|
CSV
|
Shawn R Phillips |
SELL
Payment of exercise price or tax liability
|
Direct | 20,782 Reduced 19.08% |
$806,757
$38.82 p/Share
|
Nov 21
2024 |
|
CSV
|
Shawn R Phillips |
BUY
Exercise of conversion of derivative security
|
Direct | 25,968 Added 19.26% |
$623,491
$24.01 p/Share
|
Nov 21
2024 |
|
CSV
|
Shawn R Phillips |
SELL
Open market or private sale
|
Direct | 5,028 Reduced 5.71% |
$195,890
$38.96 p/Share
|
Nov 21
2024 |
|
TRST
|
Frank B Silverman |
SELL
Sale (or disposition) back to the issuer
|
Direct | 739 Reduced 13.37% |
$27,173
$36.77 p/Share
|
Nov 21
2024 |
|
TRST
|
Frank B Silverman |
BUY
Exercise of conversion of derivative security
|
Direct | 739 Added 11.8% |
-
|
Nov 21
2024 |
|
SHW
|
John G Morikis
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 338 Added 0.09% |
$99,990
$295.83 p/Share
|
Nov 21
2024 |